TOP2A and neoplasm: The opposite behavior of AURKA and TOP2A in tumor and normal breast cells after ASncmtRNA KD could hypothetically enhance genomic instability in tumor cells on treatment with DNA-damaging drugs or radiotherapy, thereby enhancing the efficacy of treatments (and perhaps allowing for reduced dosage), whilst preserving the genomic integrity of normal cells, and thereby protecting healthy tissue from collateral damage.